Advertisement

Dexamethasone Sodium Phosphate

[09 November 2016]

Products Affected - Description

Dexamethasone Sodium Phosphate Injection, American Regent
4 mg/mL, 1 mL single dose vial, 25 count (NDC 00517-4901-25)
4 mg/mL, 5 mL multiple dose vial, 25 count (NDC 00517-4905-25)
4 mg/mL, 30 mL multiple dose vial, 25 count (NDC 00517-4930-25)
 
Dexamethasone Sodium Phosphate injection, AuroMedics
4 mg/mL, 1 mL vial, 25 count (NDC 55150-0237-01)
4 mg/mL, 5 mL vial, 25 count (NDC 55150-0238-05)
4 mg/mL, 30 mL vial, 25 count (NDC 55150-0239-30)
 
Dexamethasone Sodium Phosphate injection, West-Ward
10 mg/mL, 1 mL vial, 25 count (NDC 00641-0367-25)

Reason for the Shortage

  • American Regent has dexamethasone sodium phosphate on shortage due to manufacturing delays.
  • AuroMedics has dexamethasone sodium phosphate on intermittent back order.
  • Fresenius Kabi has most dexamethasone sodium phosphate presentations available.
  • West-Ward has dexamethasone sodium phosphate available.
  • Mylan Institutional has dexamethasone sodium phosphate available.

Available Products

Dexamethasone Sodium Phosphate injection, BD Rx
4 mg/mL, 1 mL prefilled syringe, 24 count (NDC 76045-0106-10)
 
Dexamethasone Sodium Phosphate Injection, Fresenius Kabi
4 mg/mL, 1 mL single dose vial, 25 count (NDC 63323-0165-01)
4 mg/mL, 5 mL multiple dose vial, 25 count (NDC 63323-0165-05)
4 mg/mL, 30 mL multiple dose vial, 1 count (NDC 63323-0165-30) 
10 mg/mL, 1 mL preservative-free single dose vial, 25 count (NDC 63323-0506-01)
10 mg/mL, 10 mL multiple-dose vial, 10 count (NDC 63323-0516-10)
 
Dexamethasone Sodium Phosphate Injection, Mylan Institutional
4 mg/mL, 1 mL vial, 25 count (NDC 67457-0423-12)
4 mg/mL, 5 mL vial, 25 count (NDC 67457-0422-54)
4 mg/mL, 30 mL vial, 25 count (NDC 67457-0421-30)
10 mg/mL, 10 mL vial, 10 count (NDC 67457-0420-10)

Estimated Resupply Dates

  • American Regent has dexamethasone sodium phosphate 4 mg/mL products on back order and the company cannot estimate a release date.  
  • AuroMedics has all dexamethasone sodium phosphate presentations on intermittent back order and the company is releasing product as it becomes available.
  • West-Ward has dexamethasone sodium phosphate 10 mg/mL 1 mL vials available but with an expiration date of September 2017.

Related Shortages

Updated

November 9, September 20 and 13, August 25 and 13, July 29 and 15, June 22, May 12, March 9, February 25, January 29, 2016; November 19 and 12, October 5, September 3, August 6, July 9, May 15, April 30, 16 and 2, March 25 and 13, February 25, January 16, 2015; December 5, November 14 and 4, October 15, September 26, August 1, July 23, June 23, May 29, April 30, March 11, February 21, January 24 and 8, 2014; December 27 and 9, November 26, October 28, September 18, August 27 and 14, July 31, June 27, May 3, April 12, March 20, January 23, 2013; November 9, June 21, May 25, April 17 and 10, February 29, January 18, 2012; November 23, October 26, September 30, August 18 and 4, July 22, June 23, May 23, April 22, March 24, 2011, University of Utah, Drug Information Service. Copyright 2016, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

This information is provided through the support of Vizient to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Vizient, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Vizient, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Vizient, ASHP nor University of Utah endorses or recommends the use of any drug.

« Back to Drug Shortage Product Bulletins

Advocacy Activity
Get the latest updates on ASHP's advocacy activity on drug shortages.
Advertisement
ASHP Product Listing